Bone Biologics Corporation

BBLG | NASDAQ

Price Alert Chart Builder DCF Calculator

$0.48

-$0.04 (-7.51%)

At close: Sep 21, 2026, 4:00 PM ET

$0.47

-$0.01 (-1.23%)

After-hours: Sep 21, 2026, 6:47 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $939.59K

Enterprise Value $-3.17M

Beta 0.50

Average Volume 48.41K

Shares Outstanding (Diluted) 1.8M

Shares Change YoY 222.12%

Institutional Ownership 0.25%

Exchange NASDAQ

ISIN US0980706008

Price Performance

Price Change 1M -22.6%

Price Change 3M -65.2%

Price Change 6M -57.9%

Price Change YTD -68.8%

Price Change 1Y -77.6%

Price Change 3Y -98.7%

Price Change 5Y -100.0%

1M CAGR (ann.) -43.5%

1Y CAGR (ann.) -75.4%

5Y CAGR (ann.) N/A

All-Time CAGR -83.1%

Valuation

PE Ratio -0.26

Forward PE N/A

PEG Ratio -0.00

Forward PEG 0.01

PS Ratio N/A

Forward PS N/A

PB Ratio 0.22

P/FCF Ratio -0.33

P/Adj. FCF Ratio -0.31

P/OCF Ratio -0.33

EV/Sales N/A

EV/EBIT 1.50

EV/EBITDA 1.44

EV/FCF 1.21

Earnings Yield -387.5%

FCF Yield -305.3%

Adj. FCF Yield -324.4%

Financial Health

Net Cash $4.03M

Total Debt $0

Cash & Short-Term Investments $4.03M

Total Assets $4.44M

Current Ratio 8.67

Quick Ratio 8.67

Debt / Equity Ratio 0.00

Debt / EBITDA -0.00

Debt / FCF -0.00

OCF / Debt N/A

Interest Coverage 0.00

Altman Z-Score -27.70

Piotroski F-Score 1

Margins & Profitability

Gross Profit Margin 0.0%

Operating Profit Margin 0.0%

EBITDA Margin 0.0%

Net Profit Margin 0.0%

FCF Margin N/A

Adj. FCF Margin N/A

SBC / Revenue 0.0%

SBC Impact (per share) -6.3%

Returns

Return on Assets -65.2%

Return on Equity -57.9%

Return on Invested Capital -78.0%

Return on Capital Employed -78.0%

Return on Tangible Assets -65.2%

Historical Growth (CAGR)

Revenue CAGR 3Y N/A

Revenue CAGR 5Y N/A

Revenue CAGR 10Y N/A

EPS CAGR 3Y 75.8%

EPS CAGR 5Y -50.0%

EPS CAGR 10Y 18.2%

FCF CAGR 3Y 48.9%

FCF CAGR 5Y 4.9%

FCF CAGR 10Y -2.1%

Analyst Forecasts

Analyst Rating Hold

Analyst Count 0

EPS Growth Next 3Y N/A

Revenue Growth Next 3Y N/A

Earnings Date N/A

EPS Estimate (next Q) N/A

EPS Growth Est (next Q) N/A

Revenue Est (next Q) N/A

Revenue Growth Est (next Q) N/A

Cash Flow

Operating Cash Flow $-2.63M

Free Cash Flow $-2.63M

Adj. Free Cash Flow $-2.79M

FCF Per Share -$1.46

OCF Per Share -$1.46

OCF/S Ratio 0.0%

Income Statement

Revenue $0

Gross Profit $0

Operating Income $-3.06M

EBITDA $-2.2M

Net Income $-2.89M

EPS (Diluted) -$1.86

Revenue / Employee N/A

Profit / Employee $-1.45M

Employees 2